Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RBBP4 pseudogene 4 (RBBP4P4) is a non-coding pseudogene related by sequence to the RBBP4 gene, which encodes retinoblastoma-binding protein 4. Unlike the parent RBBP4 gene—an evolutionarily conserved histone-binding and chromatin remodeling protein with well-characterized roles in cell cycle regulation, epigenetic modification, and cancer—the pseudogene RBBP4P4 does not encode a functional protein and has no described biological function, therapeutic relevance, or disease association. Pseudogenes such as RBBP4P4 may sometimes be transcribed but lack the capacity for translation into active protein. Thus, RBBP4P4 is not a therapeutic target, and entries referring to it as such are incorrect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RBBP4 pseudogene 4 (RBBP4P4).